Agenda and minutes

Venue: Committee Room 3 - Senedd. View directions

Contact: Llinos Madeley 


Senedd.TV: View the webcast

Expected timing No. Item


View the meeting transcript (PDF 227KB) View as HTML (155KB).

(09.30 - 09.45)


Scrutiny session with the Older People's Commissioner for Wales: preparation for oral evidence session

Supporting documents:


1.1 The Committee discussed its approach to the scrutiny session with the Commissioner.



Introductions, apologies and substitutions


2.1 No apologies were received.

(09.45 - 11.15)


Scrutiny session with the Older People's Commissioner for Wales: follow-up on the Committee's residential care for older people inquiry and the Commissioner's review of care homes

Sarah Rochira, the Older People’s Commissioner for Wales


Supporting information:


Note: The progress reports from both the Care and Social Services Inspectorate Wales and the Welsh Government to the Commissioner, which are referenced in the Minister’s letter, are published in annexes C and D of the Commissioner’s written evidence.

Supporting documents:


3.1 The Commissioner responded to questions from Members.

3.2 The Commissioner agreed to provide the Committee with:

·         a timeline outlining when she expects evidence of the outcomes arising from her Care Home review ‘requirements for action’ to be provided;

·         a list of the actions and follow-up work in the field of residential care that she intends to consolidate in due course.



Motion under Standing Order 17.42(vi) to resolve to exclude the public from the remainder of this meeting


4.1 The motion was agreed.

(11.15 - 11.30)


Scrutiny session with the Older People's Commissioner for Wales: consideration of evidence


5.1 The Committee considered the evidence received and agreed to write to the Commissioner and the Welsh Government to outline its views.

(11.30 - 11.45)


Legislative Consent Memorandum: Access to Medical Treatments (Innovation) Bill: consideration of approach


6.1 The Committee considered and agreed the approach to its consideration of the Legislative Consent Memorandum in relation to the Access to Medical Treatments (Innovation) Bill.